Medical Technology showcased to Taoiseach and healthcare stakeholders

6th October 2010 Dublin

Improved patient care and savings of €200 million a year highlighted Wednesday 6th October 2010: The Taoiseach and key stakeholders in Irish healthcare were provided with a showcase of medical technology that could save the Exchequer over €70 million every year, at a special event in Dublin today.

IMSTA, the association representing medical technology supply companies in Ireland, hosted the showcase of new technology, medical devices and diagnostic equipment. Some of the products on display, including stents, remote monitoring equipment and pain management devices, have been researched and developed in Ireland.

This technology facilitates earlier diagnosis, less invasive treatment options, shorter hospital stays, reduced risk of hospital infections and faster recovery times for patients. As a result, greater use of the medical technology available can reduce the overall healthcare costs in Ireland. The industry estimates that the Exchequer could benefit from savings of over €200 million every year, while facilitating improved heath care services.

Twenty of the top medical technology companies in Ireland provided the Taoiseach, TDs, health insurers, stakeholders and healthcare specialists with an insight into the vital role medical technology plays in this country.

Mr. Justin Carty, Chief Executive, IMSTA, said it was important that the key stakeholders saw for themselves the technology being developed, produced and used in Ireland.

“Medical technology can contribute to greater healthcare savings, improved quality of life for patients and job creation in this country. The industry currently employs 30,000 people and we believe that, by giving the decision makers an opportunity to see for themselves the benefits of medical technology, we can encourage a greater role for our industry in healthcare development,” he said.

Welcoming the Government’s new Research Prioritisation Steering Group, which will be investing €598 million on academic and commercially-focused research and development spread across all Government departments and agencies, Mr Carty said that there was also a need to look at the current Government procurement processes and cooperation between the Departments of Health and Enterprise.

“Patients will have faster access to new products and jobs in the medical technology supply industry will be sustained by improving the way this technology is evaluated and procured. IMSTA members also believe that the Department of Health and Children must work closely with the Enterprise department and its agencies to maximise the benefits of international medical technology companies setting up in Ireland.”

Details of the exhibits:

(The Taoiseach’s speech will also be released to the media on the day)